Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

993
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
993
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

2.0K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.0K
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

3.9K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.9K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

374
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
374
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

1.0K
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.0K
Dialysis01:27

Dialysis

1.6K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased awareness around an ultra-rare disease can improve diagnosis delays: the French example in primary hyperoxalurias.

Orphanet journal of rare diseases·2026
Same author

Outcomes and Validation of Histopathological Scores in Pediatric ANCA-vasculitis.

Kidney international reports·2026
Same author

Surfactant-coated iron oxide nanoparticles synthesized by coprecipitation as potential phosphate adsorbents in peritoneal dialysis.

Nanoscale advances·2026
Same author

Intraperitoneal pressure measurements in children on peritoneal dialysis: a review and European practice survey.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Hospital readmission in children on maintenance dialysis: a multicentre, prospective cohort study.

Clinical kidney journal·2026
Same author

Management of children and adolescents with failing kidney allografts-a review of current practice across Europe.

Pediatric nephrology (Berlin, Germany)·2026

Related Experiment Video

Updated: Feb 20, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.1K

Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy.

Maria Bartosova1, Betti Schaefer1, Justo Lorenzo Bermejo2

  • 1Division of Pediatric Nephrology, Center for Pediatric and Adolescent Medicine.

Journal of the American Society of Nephrology : JASN
|October 20, 2017
PubMed
Summary
This summary is machine-generated.

Peritoneal dialysis (PD) activates complement and TGF-β signaling in pediatric patients with chronic kidney disease (CKD). This molecular activation correlates with the severity of arteriolar vasculopathy, a key factor in cardiovascular disease.

Keywords:
TGF-betaarteriosclerosischildrencomplementperitoneal dialysisvascular disease

More Related Videos

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.3K
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

2.1K

Related Experiment Videos

Last Updated: Feb 20, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.1K
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.3K
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

2.1K

Area of Science:

  • Nephrology
  • Cardiovascular Research
  • Pediatric Medicine

Background:

  • Cardiovascular disease (CVD) is a major cause of mortality in chronic kidney disease (CKD) patients, exacerbated by peritoneal dialysis (PD).
  • Children with CKD offer a unique model to study early uremia- and PD-induced CVD mechanisms, as they lack pre-existing CVD.

Purpose of the Study:

  • To investigate the molecular mechanisms of CVD development in children undergoing PD.
  • To identify specific pathways activated by PD in arterioles.

Main Methods:

  • Transcriptomic and proteomic analyses of omental arterioles from pediatric CKD patients (pre-PD and on PD) and controls.
  • Validation in independent cohorts using microdissected omental and parietal arterioles.
  • Correlation analysis of molecular findings with clinical parameters like dialytic glucose exposure and vasculopathy severity.

Main Results:

  • Gene expression analysis revealed distinct metabolic processes in CKD arterioles and inflammatory/stress responses in PD arterioles.
  • PD arterioles showed significant upregulation of the complement system and TGF-β signaling (phosphorylated SMAD2/3).
  • Complement components (C1q, C3d, terminal complex) and pSMAD2/3 abundance correlated with dialytic glucose exposure and vasculopathy in PD patients.

Conclusions:

  • Peritoneal dialysis fluid activates complement and TGF-β signaling pathways in pediatric arterioles.
  • These activated pathways are quantitatively linked to the development and severity of arteriolar vasculopathy in children on PD.